Global Seasonal Influenza Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Global Seasonal Influenza Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Seasonal Influenza Vaccines Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Type A (H1N1)
1.2.3 Type A (H3N2)
1.2.4 Type B
1.3 Market Segment by Application
1.3.1 Global Seasonal Influenza Vaccines Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Pediatrics
1.3.3 Adolescence
1.3.4 Adults
1.3.5 Elderly
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Seasonal Influenza Vaccines Market Size (2017-2028)
2.1.1 Global Seasonal Influenza Vaccines Revenue (2017-2028)
2.1.2 Global Seasonal Influenza Vaccines Sales (2017-2028)
2.2 Global Seasonal Influenza Vaccines Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Seasonal Influenza Vaccines Sales by Regions (2017-2022)
2.2.2 Global Seasonal Influenza Vaccines Revenue by Regions (2017-2022)
2.3 Global Seasonal Influenza Vaccines Market Size Forecast by Region
2.3.1 Global Seasonal Influenza Vaccines Sales Forecast by Region (2023-2028)
2.3.2 Global Seasonal Influenza Vaccines Revenue Forecast by Region (2023-2028)
2.4 Global Top Seasonal Influenza Vaccines Regions (Countries) Ranking by Market Size
2.5 Seasonal Influenza Vaccines Market Dynamics
2.5.1 Seasonal Influenza Vaccines Market Trends
2.5.2 Seasonal Influenza Vaccines Market Drivers
2.5.3 Seasonal Influenza Vaccines Market Challenges
2.5.4 Seasonal Influenza Vaccines Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Seasonal Influenza Vaccines Manufacturers by Sales (2017-2022)
3.1.1 Global Seasonal Influenza Vaccines Sales by Manufacturers (2017-2022)
3.1.2 Global Seasonal Influenza Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Seasonal Influenza Vaccines Sales in 2021
3.2 Global Top Manufacturers Seasonal Influenza Vaccines by Revenue
3.2.1 Global Seasonal Influenza Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Top Seasonal Influenza Vaccines Manufacturers Covered: Ranking by Revenue
3.2.3 Global Seasonal Influenza Vaccines Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Seasonal Influenza Vaccines Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Seasonal Influenza Vaccines as of 2021)
3.4 Global Seasonal Influenza Vaccines Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Seasonal Influenza Vaccines Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Seasonal Influenza Vaccines Market
3.7 Key Manufacturers Seasonal Influenza Vaccines Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Seasonal Influenza Vaccines Market Size by Type
4.1 Global Seasonal Influenza Vaccines Historic Market Review by Type (2017-2022)
4.1.1 Global Seasonal Influenza Vaccines Sales Market Share by Type (2017-2022)
4.1.2 Global Seasonal Influenza Vaccines Revenue Market Share by Type (2017-2022)
4.1.3 Seasonal Influenza Vaccines Price by Type (2017-2022)
4.2 Global Seasonal Influenza Vaccines Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Seasonal Influenza Vaccines Sales Forecast by Type (2023-2028)
4.2.2 Global Seasonal Influenza Vaccines Revenue Forecast by Type (2023-2028)
4.2.3 Seasonal Influenza Vaccines Price Forecast by Type (2023-2028)
5 Global Seasonal Influenza Vaccines Market Size by Application
5.1 Global Seasonal Influenza Vaccines Historic Market Review by Application (2017-2022)
5.1.1 Global Seasonal Influenza Vaccines Sales Market Share by Application (2017-2022)
5.1.2 Global Seasonal Influenza Vaccines Revenue Market Share by Application (2017-2022)
5.1.3 Seasonal Influenza Vaccines Price by Application (2017-2022)
5.2 Global Seasonal Influenza Vaccines Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Seasonal Influenza Vaccines Sales Forecast by Application (2023-2028)
5.2.2 Global Seasonal Influenza Vaccines Revenue Forecast by Application (2023-2028)
5.2.3 Seasonal Influenza Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Seasonal Influenza Vaccines Sales Breakdown by Company
6.1.1 North America Seasonal Influenza Vaccines Sales by Company (2017-2022)
6.1.2 North America Seasonal Influenza Vaccines Revenue by Company (2017-2022)
6.2 North America Seasonal Influenza Vaccines Market Size by Type
6.2.1 North America Seasonal Influenza Vaccines Sales by Type (2017-2028)
6.2.2 North America Seasonal Influenza Vaccines Revenue by Type (2017-2028)
6.3 North America Seasonal Influenza Vaccines Market Size by Application
6.3.1 North America Seasonal Influenza Vaccines Sales by Application (2017-2028)
6.3.2 North America Seasonal Influenza Vaccines Revenue by Application (2017-2028)
6.4 North America Seasonal Influenza Vaccines Market Size by Country
6.4.1 North America Seasonal Influenza Vaccines Sales by Country (2017-2028)
6.4.2 North America Seasonal Influenza Vaccines Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Seasonal Influenza Vaccines Sales Breakdown by Company
7.1.1 Europe Seasonal Influenza Vaccines Sales by Company (2017-2022)
7.1.2 Europe Seasonal Influenza Vaccines Revenue by Company (2017-2022)
7.2 Europe Seasonal Influenza Vaccines Market Size by Type
7.2.1 Europe Seasonal Influenza Vaccines Sales by Type (2017-2028)
7.2.2 Europe Seasonal Influenza Vaccines Revenue by Type (2017-2028)
7.3 Europe Seasonal Influenza Vaccines Market Size by Application
7.3.1 Europe Seasonal Influenza Vaccines Sales by Application (2017-2028)
7.3.2 Europe Seasonal Influenza Vaccines Revenue by Application (2017-2028)
7.4 Europe Seasonal Influenza Vaccines Market Size by Country
7.4.1 Europe Seasonal Influenza Vaccines Sales by Country (2017-2028)
7.4.2 Europe Seasonal Influenza Vaccines Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Seasonal Influenza Vaccines Sales Breakdown by Company
8.1.1 Asia Pacific Seasonal Influenza Vaccines Sales by Company (2017-2022)
8.1.2 Asia Pacific Seasonal Influenza Vaccines Revenue by Company (2017-2022)
8.2 Asia Pacific Seasonal Influenza Vaccines Market Size by Type
8.2.1 Asia Pacific Seasonal Influenza Vaccines Sales by Type (2017-2028)
8.2.2 Asia Pacific Seasonal Influenza Vaccines Revenue by Type (2017-2028)
8.3 Asia Pacific Seasonal Influenza Vaccines Market Size by Application
8.3.1 Asia Pacific Seasonal Influenza Vaccines Sales by Application (2017-2028)
8.3.2 Asia Pacific Seasonal Influenza Vaccines Revenue by Application (2017-2028)
8.4 Asia Pacific Seasonal Influenza Vaccines Market Size by Region
8.4.1 Asia Pacific Seasonal Influenza Vaccines Sales by Region
8.4.2 Asia Pacific Seasonal Influenza Vaccines Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Seasonal Influenza Vaccines Sales Breakdown by Company
9.1.1 Latin America Seasonal Influenza Vaccines Sales by Company (2017-2022)
9.1.2 Latin America Seasonal Influenza Vaccines Revenue by Company (2017-2022)
9.2 Latin America Seasonal Influenza Vaccines Market Size by Type
9.2.1 Latin America Seasonal Influenza Vaccines Sales by Type (2017-2028)
9.2.2 Latin America Seasonal Influenza Vaccines Revenue by Type (2017-2028)
9.3 Latin America Seasonal Influenza Vaccines Market Size by Application
9.3.1 Latin America Seasonal Influenza Vaccines Sales by Application (2017-2028)
9.3.2 Latin America Seasonal Influenza Vaccines Revenue by Application (2017-2028)
9.4 Latin America Seasonal Influenza Vaccines Market Size by Country
9.4.1 Latin America Seasonal Influenza Vaccines Sales by Country (2017-2028)
9.4.2 Latin America Seasonal Influenza Vaccines Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Seasonal Influenza Vaccines Sales Breakdown by Company
10.1.1 Middle East and Africa Seasonal Influenza Vaccines Sales by Company (2017-2022)
10.1.2 Middle East and Africa Seasonal Influenza Vaccines Revenue by Company (2017-2022)
10.2 Middle East and Africa Seasonal Influenza Vaccines Market Size by Type
10.2.1 Middle East and Africa Seasonal Influenza Vaccines Sales by Type (2017-2028)
10.2.2 Middle East and Africa Seasonal Influenza Vaccines Revenue by Type (2017-2028)
10.3 Middle East and Africa Seasonal Influenza Vaccines Market Size by Application
10.3.1 Middle East and Africa Seasonal Influenza Vaccines Sales by Application (2017-2028)
10.3.2 Middle East and Africa Seasonal Influenza Vaccines Revenue by Application (2017-2028)
10.4 Middle East and Africa Seasonal Influenza Vaccines Market Size by Country
10.4.1 Middle East and Africa Seasonal Influenza Vaccines Sales by Country (2017-2028)
10.4.2 Middle East and Africa Seasonal Influenza Vaccines Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 U.A.E
11 Company Profiles
11.1 GlaxoSmithKline plc
11.1.1 GlaxoSmithKline plc Corporation Information
11.1.2 GlaxoSmithKline plc Overview
11.1.3 GlaxoSmithKline plc Seasonal Influenza Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 GlaxoSmithKline plc Seasonal Influenza Vaccines Products and Services
11.1.5 GlaxoSmithKline plc Seasonal Influenza Vaccines SWOT Analysis
11.1.6 GlaxoSmithKline plc Recent Developments
11.2 Sinovac Biotech Ltd
11.2.1 Sinovac Biotech Ltd Corporation Information
11.2.2 Sinovac Biotech Ltd Overview
11.2.3 Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Sinovac Biotech Ltd Seasonal Influenza Vaccines Products and Services
11.2.5 Sinovac Biotech Ltd Seasonal Influenza Vaccines SWOT Analysis
11.2.6 Sinovac Biotech Ltd Recent Developments
11.3 Changsheng Bio-Technology
11.3.1 Changsheng Bio-Technology Corporation Information
11.3.2 Changsheng Bio-Technology Overview
11.3.3 Changsheng Bio-Technology Seasonal Influenza Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Changsheng Bio-Technology Seasonal Influenza Vaccines Products and Services
11.3.5 Changsheng Bio-Technology Seasonal Influenza Vaccines SWOT Analysis
11.3.6 Changsheng Bio-Technology Recent Developments
11.4 Ccbio SA
11.4.1 Ccbio SA Corporation Information
11.4.2 Ccbio SA Overview
11.4.3 Ccbio SA Seasonal Influenza Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Ccbio SA Seasonal Influenza Vaccines Products and Services
11.4.5 Ccbio SA Seasonal Influenza Vaccines SWOT Analysis
11.4.6 Ccbio SA Recent Developments
11.5 Aleph Biomedical
11.5.1 Aleph Biomedical Corporation Information
11.5.2 Aleph Biomedical Overview
11.5.3 Aleph Biomedical Seasonal Influenza Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Aleph Biomedical Seasonal Influenza Vaccines Products and Services
11.5.5 Aleph Biomedical Seasonal Influenza Vaccines SWOT Analysis
11.5.6 Aleph Biomedical Recent Developments
11.6 Sanofi
11.6.1 Sanofi Corporation Information
11.6.2 Sanofi Overview
11.6.3 Sanofi Seasonal Influenza Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Sanofi Seasonal Influenza Vaccines Products and Services
11.6.5 Sanofi Seasonal Influenza Vaccines SWOT Analysis
11.6.6 Sanofi Recent Developments
11.7 Jiangsu Simcere Vaxtec Bio-pharmaceutical
11.7.1 Jiangsu Simcere Vaxtec Bio-pharmaceutical Corporation Information
11.7.2 Jiangsu Simcere Vaxtec Bio-pharmaceutical Overview
11.7.3 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Products and Services
11.7.5 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines SWOT Analysis
11.7.6 Jiangsu Simcere Vaxtec Bio-pharmaceutical Recent Developments
11.8 Dalian Hissen Bio-pharm
11.8.1 Dalian Hissen Bio-pharm Corporation Information
11.8.2 Dalian Hissen Bio-pharm Overview
11.8.3 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Products and Services
11.8.5 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines SWOT Analysis
11.8.6 Dalian Hissen Bio-pharm Recent Developments
11.9 Abbott Laboratories
11.9.1 Abbott Laboratories Corporation Information
11.9.2 Abbott Laboratories Overview
11.9.3 Abbott Laboratories Seasonal Influenza Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 Abbott Laboratories Seasonal Influenza Vaccines Products and Services
11.9.5 Abbott Laboratories Seasonal Influenza Vaccines SWOT Analysis
11.9.6 Abbott Laboratories Recent Developments
11.10 Novartis International AG
11.10.1 Novartis International AG Corporation Information
11.10.2 Novartis International AG Overview
11.10.3 Novartis International AG Seasonal Influenza Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 Novartis International AG Seasonal Influenza Vaccines Products and Services
11.10.5 Novartis International AG Seasonal Influenza Vaccines SWOT Analysis
11.10.6 Novartis International AG Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Seasonal Influenza Vaccines Value Chain Analysis
12.2 Seasonal Influenza Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Seasonal Influenza Vaccines Production Mode & Process
12.4 Seasonal Influenza Vaccines Sales and Marketing
12.4.1 Seasonal Influenza Vaccines Sales Channels
12.4.2 Seasonal Influenza Vaccines Distributors
12.5 Seasonal Influenza Vaccines Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Seasonal Influenza Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Type A (H1N1)
Table 3. Major Manufacturers of Type A (H3N2)
Table 4. Major Manufacturers of Type B
Table 5. Global Seasonal Influenza Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Seasonal Influenza Vaccines Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 7. Global Seasonal Influenza Vaccines Sales by Region (2017-2022) & (K Units)
Table 8. Global Seasonal Influenza Vaccines Sales Market Share by Region (2017-2022)
Table 9. Global Seasonal Influenza Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Seasonal Influenza Vaccines Revenue Market Share by Region (2017-2022)
Table 11. Global Seasonal Influenza Vaccines Sales Forecast by Region (2023-2028) & (K Units)
Table 12. Global Seasonal Influenza Vaccines Sales Market Share Forecast by Region (2023-2028)
Table 13. Global Seasonal Influenza Vaccines Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 14. Global Seasonal Influenza Vaccines Revenue Market Share Forecast by Region (2023-2028)
Table 15. Top Seasonal Influenza Vaccines Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 16. Seasonal Influenza Vaccines Market Trends
Table 17. Seasonal Influenza Vaccines Market Drivers
Table 18. Seasonal Influenza Vaccines Market Challenges
Table 19. Seasonal Influenza Vaccines Market Restraints
Table 20. Global Seasonal Influenza Vaccines Sales by Manufacturers (2017-2022) & (K Units)
Table 21. Global Seasonal Influenza Vaccines Sales Share by Manufacturers (2017-2022)
Table 22. Global Seasonal Influenza Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 23. Ranking of Global Top Seasonal Influenza Vaccines Manufacturers by Revenue (US$ Million) in 2021
Table 24. Seasonal Influenza Vaccines Revenue Share by Manufacturers (2017-2022)
Table 25. Global Seasonal Influenza Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Seasonal Influenza Vaccines as of 2021)
Table 27. Key Manufacturers Seasonal Influenza Vaccines Average Selling Price (ASP) & (2017-2022) & (USD/Unit)
Table 28. Key Manufacturers Seasonal Influenza Vaccines Plants/Factories Distribution
Table 29. Key Manufacturers Seasonal Influenza Vaccines Area Served
Table 30. Date of Key Manufacturers Enter into Seasonal Influenza Vaccines Market
Table 31. Key Manufacturers Seasonal Influenza Vaccines Product Type
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Seasonal Influenza Vaccines Sales (K Units) by Type (2017-2022)
Table 34. Global Seasonal Influenza Vaccines Sales Share by Type (2017-2022)
Table 35. Global Seasonal Influenza Vaccines Revenue (US$ Million) Market Share by Type (2017-2022)
Table 36. Global Seasonal Influenza Vaccines Price (K Units) by Type (2017-2022)
Table 37. Global Seasonal Influenza Vaccines Sales (K Units) by Type (2023-2028)
Table 38. Global Seasonal Influenza Vaccines Sales Share by Type (2023-2028)
Table 39. Global Seasonal Influenza Vaccines Revenue (US$ Million) Market Share by Type (2023-2028)
Table 40. Global Seasonal Influenza Vaccines Revenue Share by Type (2023-2028)
Table 41. Global Seasonal Influenza Vaccines Price (K Units) by Type (2023-2028)
Table 42. Global Seasonal Influenza Vaccines Sales (K Units) by Application (2017-2022)
Table 43. Global Seasonal Influenza Vaccines Sales Share by Application (2017-2022)
Table 44. Global Seasonal Influenza Vaccines Revenue (US$ Million) Market Share by Application (2017-2022)
Table 45. Global Seasonal Influenza Vaccines Price (K Units) by Application (2017-2022)
Table 46. Global Seasonal Influenza Vaccines Sales (K Units) by Application (2023-2028)
Table 47. Global Seasonal Influenza Vaccines Sales Share by Application (2023-2028)
Table 48. Global Seasonal Influenza Vaccines Revenue (US$ Million) Market Share by Application (2023-2028)
Table 49. Global Seasonal Influenza Vaccines Revenue Share by Application (2023-2028)
Table 50. Global Seasonal Influenza Vaccines Price (K Units) by Application (2023-2028)
Table 51. North America Seasonal Influenza Vaccines Sales by Company (2017-2022) & (K Units)
Table 52. North America Seasonal Influenza Vaccines Sales Market Share by Company (2017-2022)
Table 53. North America Seasonal Influenza Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 54. North America Seasonal Influenza Vaccines Revenue Market Share by Company (2017-2022)
Table 55. North America Seasonal Influenza Vaccines Sales by Type (2017-2022) & (K Units)
Table 56. North America Seasonal Influenza Vaccines Sales by Type (2023-2028) & (K Units)
Table 57. North America Seasonal Influenza Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 58. North America Seasonal Influenza Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 59. North America Seasonal Influenza Vaccines Sales by Application (2017-2022) & (K Units)
Table 60. North America Seasonal Influenza Vaccines Sales by Application (2023-2028) & (K Units)
Table 61. North America Seasonal Influenza Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 62. North America Seasonal Influenza Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 63. North America Seasonal Influenza Vaccines Sales by Country (2017-2022) & (K Units)
Table 64. North America Seasonal Influenza Vaccines Sales by Country (2023-2028) & (K Units)
Table 65. North America Seasonal Influenza Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 66. North America Seasonal Influenza Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 67. Europe Seasonal Influenza Vaccines Sales by Company (2017-2022) & (K Units)
Table 68. Europe Seasonal Influenza Vaccines Sales Market Share by Company (2017-2022)
Table 69. Europe Seasonal Influenza Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 70. Europe Seasonal Influenza Vaccines Revenue Market Share by Company (2017-2022)
Table 71. Europe Seasonal Influenza Vaccines Sales by Type (2017-2022) & (K Units)
Table 72. Europe Seasonal Influenza Vaccines Sales by Type (2023-2028) & (K Units)
Table 73. Europe Seasonal Influenza Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 74. Europe Seasonal Influenza Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 75. Europe Seasonal Influenza Vaccines Sales by Application (2017-2022) & (K Units)
Table 76. Europe Seasonal Influenza Vaccines Sales by Application (2023-2028) & (K Units)
Table 77. Europe Seasonal Influenza Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 78. Europe Seasonal Influenza Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 79. Europe Seasonal Influenza Vaccines Sales by Country (2017-2022) & (K Units)
Table 80. Europe Seasonal Influenza Vaccines Sales by Country (2023-2028) & (K Units)
Table 81. Europe Seasonal Influenza Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 82. Europe Seasonal Influenza Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 83. Asia Pacific Seasonal Influenza Vaccines Sales by Company (2017-2022) & (K Units)
Table 84. Asia Pacific Seasonal Influenza Vaccines Sales Market Share by Company (2017-2022)
Table 85. Asia Pacific Seasonal Influenza Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 86. Asia Pacific Seasonal Influenza Vaccines Revenue Market Share by Company (2017-2022)
Table 87. Asia Pacific Seasonal Influenza Vaccines Sales by Type (2017-2022) & (K Units)
Table 88. Asia Pacific Seasonal Influenza Vaccines Sales by Type (2023-2028) & (K Units)
Table 89. Asia Pacific Seasonal Influenza Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 90. Asia Pacific Seasonal Influenza Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 91. Asia Pacific Seasonal Influenza Vaccines Sales by Application (2017-2022) & (K Units)
Table 92. Asia Pacific Seasonal Influenza Vaccines Sales by Application (2023-2028) & (K Units)
Table 93. Asia Pacific Seasonal Influenza Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 94. Asia Pacific Seasonal Influenza Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 95. Asia Pacific Seasonal Influenza Vaccines Sales by Region (2017-2022) & (K Units)
Table 96. Asia Pacific Seasonal Influenza Vaccines Sales by Region (2023-2028) & (K Units)
Table 97. Asia Pacific Seasonal Influenza Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 98. Asia Pacific Seasonal Influenza Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 99. Latin America Seasonal Influenza Vaccines Sales by Company (2017-2022) & (K Units)
Table 100. Latin America Seasonal Influenza Vaccines Sales Market Share by Company (2017-2022)
Table 101. Latin America Seasonal Influenza Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 102. Latin America Seasonal Influenza Vaccines Revenue Market Share by Company (2017-2022)
Table 103. Latin America Seasonal Influenza Vaccines Sales by Type (2017-2022) & (K Units)
Table 104. Latin America Seasonal Influenza Vaccines Sales by Type (2023-2028) & (K Units)
Table 105. Latin America Seasonal Influenza Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 106. Latin America Seasonal Influenza Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 107. Latin America Seasonal Influenza Vaccines Sales by Application (2017-2022) & (K Units)
Table 108. Latin America Seasonal Influenza Vaccines Sales by Application (2023-2028) & (K Units)
Table 109. Latin America Seasonal Influenza Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 110. Latin America Seasonal Influenza Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 111. Latin America Seasonal Influenza Vaccines Sales by Country (2017-2022) & (K Units)
Table 112. Latin America Seasonal Influenza Vaccines Sales by Country (2023-2028) & (K Units)
Table 113. Latin America Seasonal Influenza Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 114. Latin America Seasonal Influenza Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 115. Middle East and Africa Seasonal Influenza Vaccines Sales by Company (2017-2022) & (K Units)
Table 116. Middle East and Africa Seasonal Influenza Vaccines Sales Market Share by Company (2017-2022)
Table 117. Middle East and Africa Seasonal Influenza Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 118. Middle East and Africa Seasonal Influenza Vaccines Revenue Market Share by Company (2017-2022)
Table 119. Middle East and Africa Seasonal Influenza Vaccines Sales by Type (2017-2022) & (K Units)
Table 120. Middle East and Africa Seasonal Influenza Vaccines Sales by Type (2023-2028) & (K Units)
Table 121. Middle East and Africa Seasonal Influenza Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 122. Middle East and Africa Seasonal Influenza Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 123. Middle East and Africa Seasonal Influenza Vaccines Sales by Application (2017-2022) & (K Units)
Table 124. Middle East and Africa Seasonal Influenza Vaccines Sales by Application (2023-2028) & (K Units)
Table 125. Middle East and Africa Seasonal Influenza Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 126. Middle East and Africa Seasonal Influenza Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 127. Middle East and Africa Seasonal Influenza Vaccines Sales by Country (2017-2022) & (K Units)
Table 128. Middle East and Africa Seasonal Influenza Vaccines Sales by Country (2023-2028) & (K Units)
Table 129. Middle East and Africa Seasonal Influenza Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 130. Middle East and Africa Seasonal Influenza Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 131. GlaxoSmithKline plc Corporation Information
Table 132. GlaxoSmithKline plc Description and Overview
Table 133. GlaxoSmithKline plc Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 134. GlaxoSmithKline plc Seasonal Influenza Vaccines Product and Services
Table 135. GlaxoSmithKline plc Seasonal Influenza Vaccines SWOT Analysis
Table 136. GlaxoSmithKline plc Recent Developments
Table 137. Sinovac Biotech Ltd Corporation Information
Table 138. Sinovac Biotech Ltd Description and Overview
Table 139. Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 140. Sinovac Biotech Ltd Seasonal Influenza Vaccines Product and Services
Table 141. Sinovac Biotech Ltd Seasonal Influenza Vaccines SWOT Analysis
Table 142. Sinovac Biotech Ltd Recent Developments
Table 143. Changsheng Bio-Technology Corporation Information
Table 144. Changsheng Bio-Technology Description and Overview
Table 145. Changsheng Bio-Technology Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 146. Changsheng Bio-Technology Seasonal Influenza Vaccines Product and Services
Table 147. Changsheng Bio-Technology Seasonal Influenza Vaccines SWOT Analysis
Table 148. Changsheng Bio-Technology Recent Developments
Table 149. Ccbio SA Corporation Information
Table 150. Ccbio SA Description and Overview
Table 151. Ccbio SA Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 152. Ccbio SA Seasonal Influenza Vaccines Product and Services
Table 153. Ccbio SA Seasonal Influenza Vaccines SWOT Analysis
Table 154. Ccbio SA Recent Developments
Table 155. Aleph Biomedical Corporation Information
Table 156. Aleph Biomedical Description and Overview
Table 157. Aleph Biomedical Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 158. Aleph Biomedical Seasonal Influenza Vaccines Product and Services
Table 159. Aleph Biomedical Seasonal Influenza Vaccines SWOT Analysis
Table 160. Aleph Biomedical Recent Developments
Table 161. Sanofi Corporation Information
Table 162. Sanofi Description and Overview
Table 163. Sanofi Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 164. Sanofi Seasonal Influenza Vaccines Product and Services
Table 165. Sanofi Seasonal Influenza Vaccines SWOT Analysis
Table 166. Sanofi Recent Developments
Table 167. Jiangsu Simcere Vaxtec Bio-pharmaceutical Corporation Information
Table 168. Jiangsu Simcere Vaxtec Bio-pharmaceutical Description and Overview
Table 169. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 170. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Product and Services
Table 171. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines SWOT Analysis
Table 172. Jiangsu Simcere Vaxtec Bio-pharmaceutical Recent Developments
Table 173. Dalian Hissen Bio-pharm Corporation Information
Table 174. Dalian Hissen Bio-pharm Description and Overview
Table 175. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 176. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Product and Services
Table 177. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines SWOT Analysis
Table 1

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs